[{"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91749", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0356-2023", "product_description": "Norepinephrine Bitartrate in 0.9% Sodium Chloride Injection, USP, 8 mg/250 mL (32 mcg/mL*), 250 mL Single-Dose Container, packaged in 15 x 1 IV Bottles per carton, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-316-25.", "product_quantity": "443,483 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230222", "center_classification_date": "20230227", "termination_date": "20240924", "report_date": "20230308", "code_info": "Lots: NB2015A, Exp. 02/27/2023; NB2016A, Exp. 02/19/2023; NB2021A, Exp. 03/05/2023; NB2023A, Exp. 03/12/2023; NB2026A, Exp. 03/29/2023; NB2029A, Exp. 04/21/2023; NB2031A, Exp. 04/21/2023; NB2033A, Exp. 05/10/2023; NB2034A, Exp. 05/19/2023; NB2037A, Exp. 05/25/2023; NB2039A, Exp. 06/05/2023; NB2041A, Exp. 06/14/2023; NB2044A, Exp. 06/18/2023; NB2050A, Exp. 07/19/2023; NB2054A, Exp. 08/04/2023; NB2057A, Exp. 08/12/2023; NB2059A, Exp. 08/20/2023; NB2061A, Exp. 09/14/2023; NB2067A, Exp. 09/22/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67080", "recalling_firm": "Zions RX Formulations Services LLC dba RX Formuations Serv.", "address_1": "5949 E University Dr", "address_2": "N/A", "postal_code": "85205-7435", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "AZ", "recall_number": "D-1213-2014", "product_description": "Calcium Gluconate 10% for Injection, SDV 100 mL SDV, PF, Not for Dispensing, For Hospital Administration Only, Rx Formulations, 5949 East University Drive, Mesa, AZ, 85205.", "product_quantity": "450 Vials", "reason_for_recall": "Non-Sterility: RX Formulation initiated this recall due to a report of microbial contamination found in Calcium Gluconate saturated solution that was observed upon drawing the vial contents into a syringe.", "recall_initiation_date": "20131212", "center_classification_date": "20140407", "termination_date": "20140501", "report_date": "20140416", "code_info": "Lot #: 117433@15 Expiration Date: 12/07/2013   Lot #: 117446@8 Expiration Date: 12/12/2013   Lot#: 117923@8 Expiration Date: 12/19/2013"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; carBAMazepine ER, Capsule, 200 mg may be potentially mislabeled as    ACAMPROSATE CALCIUM DR, Tablet, 333 mg, NDC 00456333001, Pedigree: AD46333_1, EXP: 5/15/2014.", "address_2": "", "product_quantity": "229 Capsules", "code_info": "carBAMazepine ER, Capsule, 200 mg has the following code    Pedigree: AD32764_14, EXP: 5/14/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "carBAMazepine ER, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 66993040832", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-719-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76982", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "N/A", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0671-2017", "product_description": "BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, packaged in a) 60-count bottles (NDC 59746-317-60) and b) 100-count bottles (NDC 59746-317-01), Rx only, Manufactured by: Julibant Life Sciences Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD  21801, USA.", "product_quantity": "19,682 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.", "recall_initiation_date": "20160408", "center_classification_date": "20170413", "termination_date": "20170417", "report_date": "20170419", "code_info": "Lot #s: a) BU34002A, BU34003A, Exp 11/16; b) BU34001A, Exp 10/16", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "26 units", "code_info": "Rx #'s:   0387528    0395197    0389191      0390909    0406810    0409865    0388591    0388594    0388595    0388597    0388598    0388599    0388602    0388604    0391126    0390909      0390909        0397860    0400856    0402992    0404849    0406843", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DIPHENHYDRAMINE  25MG/ML INJECTABLE 90 ML; DIPHENHYDRAMINE 50MG/ML INJECTABLE 10 ML, 100 ML, 108 ML, 120 MLS, 25 ML, 32 ML, 60 ML, 90 ML, 90 MLS; DIPHENHYDRAMINE, SDV, 25X1ML** 50MG/ML INJECTABLE 25 ML (11 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1503-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Ridgeland", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90798", "recalling_firm": "Carolina Infusion", "address_1": "95 Bees Creek Rd", "address_2": "", "postal_code": "29936-7540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1527-2022", "product_description": "TRI-MIX 30/1/20 Injectable, 5 ML vial, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.", "product_quantity": "7 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220826", "center_classification_date": "20220915", "report_date": "20220921", "code_info": "Lots: 06272022@6 BUD: 08/26/2022; 07212022@3 BUD: 09/19/2022; 07292022@11 BUD: 09/27/2022; 08052022@7 BUD: 10/04/2022; 08102022@5 BUD: 10/09/2022;  08122022@14 BUD: 10/11/2022; 08172022@7 BUD: 10/16/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "93261", "recalling_firm": "VistaPharm LLC", "address_1": "7265 Ulmerton Rd", "address_2": "", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide USA", "recall_number": "D-0126-2024", "product_description": "Aminocaproic Acid Oral Solution, 0.25 grams/mL, Rx only, packaged in 8 Fl. Oz. (236.5 mL) HDPE bottles, Manufactured for: VistaPharm, Inc., Largo, FL 33771, UAS, NDC 66689-330-08", "product_quantity": "Prod Lot number 22ZKY1, EXP 11/27/23, 600 bottles dist; 22ZMC1 EXP12/21/23 600 bottles; 22ZTP1 EXP 03/29/24 588 bottles; 23ZAD1 EXP 07/07/24 564 bottl", "reason_for_recall": "Failed Excipient Specifications: high content of ethylene glycol (EG)", "recall_initiation_date": "20231017", "center_classification_date": "20231128", "termination_date": "20240726", "report_date": "20231206", "code_info": "Lot #: 22ZKY1, Exp. 11/27/23; 22ZMC1, Exp. 12/21/23; 22ZTP1, Exp. 03/29/24; 23ZAD1, Exp. 07/07/24.", "more_code_info": ""}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "20", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Hydromorphone HCI 0.4mg/mL in 0.9% Sodium Chloride 30 mL fill in a 35 mL Monoject Plungerless syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0684-68", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1292-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-303-2014", "product_description": "Testosterone Pellets 225mg, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "3714 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-716-2015", "product_description": "Hydrocortisone Sodium Succinate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "6100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-901-2015", "product_description": "Sodium Starch Glycolate pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "4000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Glendora", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "72517", "recalling_firm": "Oasis Medical, Inc.", "address_1": "514 S. Vermont Ave Bldg 510-528", "address_2": "N/A", "postal_code": "91741-6205", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Saudi Arabia, Israel, Chile, Norway, Ecuador, Greece, Switzerland, Canada, England, Columbia, Poland, South Africa, Germany, Pakistan, El Salvador, Dubai, Belgium", "recall_number": "D-0524-2016", "product_description": "HPMC Visoelastic, 8,000 cps, Reference 51082, LT5108 (Private Label), 2.0 mL in 3-mL Syringe, OASIS Medical Inc, 514 South Vermont Avenue Glendora, CA 91741", "product_quantity": "14,852 units", "reason_for_recall": "Failed pH Specification: It has been determined that the pH of the lots recalled, may not meet specification at expiry.", "recall_initiation_date": "20151019", "center_classification_date": "20151222", "termination_date": "20160314", "report_date": "20151230", "code_info": "Lot #: V0814C, V0814D, Exp 8/2016; V1014A, V1014B, Exp 10/2016; V1214C, Exp 12/2016;  V0115A, V0115B, Exp 01/2017;  V0215C, Exp 02/2017; V0315C, V0315D, Exp 03/2017; V0515A, V0515B, Exp 05/2017."}, {"status": "Terminated", "city": "Dallas", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "66878", "recalling_firm": "Fossil Fuel Products, LLC", "address_1": "138 Sedgefield Overlook", "address_2": "N/A", "postal_code": "30157", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-1248-2014", "product_description": "RezzRX capsules, Single Blister Pack and 20 count bottle,  Distributed By: Fossil Fuel Products, LLC Atlanta, GA 30309", "product_quantity": "50,300 capsules", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Fossil Fuel Products, is recalling  RezzRX due to undeclared  hydroxylthiohomosildenafil and aminotadalafil.", "recall_initiation_date": "20131118", "center_classification_date": "20140418", "termination_date": "20150529", "report_date": "20140430", "code_info": "Lots QL110408B046, QL110714A102  Exp. 11/13", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0740-2019", "product_description": "Dr. King's SafeCare Rx Better Breath Oral Health, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955630128, NDC 57955-6302-2", "product_quantity": "12 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 060116G Exp. 06/19; 020817F Exp. 02/20"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-319-2014", "product_description": "Tri-Mix SS Pap 30mg, Phen 1mg, PGE1 10mcg  5ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "1 unit", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63509", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-017-2013", "product_description": "Necon 1/35-28 (norethindrone and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Pharma, Inc., A subsidiary of Watson Pharmaceuticals, Inc., Corona, CA  92880 USA; NDC 52544-552-28.", "product_quantity": "6,466 cartons", "reason_for_recall": "Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).", "recall_initiation_date": "20121019", "center_classification_date": "20121024", "termination_date": "20131121", "report_date": "20121031", "code_info": "Lot #: 514743AB, Exp 09/30/13"}, {"country": "United States", "city": "Lake Forest", "address_1": "600 N Field Dr Bldg J45", "reason_for_recall": "CGMP Deviations: Shipment of product not approved for release.", "address_2": "", "product_quantity": "1,296 units", "code_info": "Lot 16-836-FW, Exp 04/14", "center_classification_date": "20130322", "distribution_pattern": "NC", "state": "IL", "product_description": "Lactated Ringer's Injection, USP, 1000 mL, Rx only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7953-09", "report_date": "20130403", "classification": "Class III", "openfda": {}, "recalling_firm": "Hospira, Inc.", "recall_number": "D-215-2013", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "63242", "termination_date": "20130328", "more_code_info": "", "recall_initiation_date": "20120621", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0661-2023", "product_description": "Cardioplegia Solution, Maintenance 4:1 low potassium, 20 mEq K, packaged in 810 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0103-1.", "product_quantity": "269 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-893803, Exp 04/28/2023; 37-896483, Exp 05/07/2023; 37-897939, Exp 05/13/2023; 37-900952, Exp 05/26/2023"}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210614"], "brand_name": ["NIFEDIPINE"], "generic_name": ["NIFEDIPINE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7081", "0904-7080", "0904-7082"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NIFEDIPINE"], "spl_id": ["af49dd32-02ac-47ab-b513-ca480fe8dc36"], "spl_set_id": ["41aa6fbd-96c1-40f7-92d4-cfdd2d5325e9"], "package_ndc": ["0904-7080-06", "0904-7080-61", "0904-7081-06", "0904-7081-61", "0904-7082-04", "0904-7082-06"], "original_packager_product_ndc": ["50742-260", "50742-261", "50742-262"], "upc": ["0309047080618"], "nui": ["N0000000069", "N0000175421", "M0006414"], "pharm_class_moa": ["Calcium Channel Antagonists [MoA]"], "pharm_class_epc": ["Dihydropyridine Calcium Channel Blocker [EPC]"], "pharm_class_cs": ["Dihydropyridines [CS]"], "unii": ["I9ZF7L6G2L"]}, "product_type": "Drugs", "event_id": "88224", "recalling_firm": "The Harvard Drug Group", "address_1": "17187 N Laurel Park Dr Ste 300", "address_2": "", "postal_code": "48152-2600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in OH and NJ", "recall_number": "D-0652-2021", "product_description": "NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit dose carton, NDC 0904-7080-61; b) 50 count unit dose carton, NDC 0904-7080-06: Distributed by: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408  Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA", "product_quantity": "504 Cartons of 50 count each; 372 Cartons of 100 count each", "reason_for_recall": "Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.", "recall_initiation_date": "20210702", "center_classification_date": "20210709", "termination_date": "20221228", "report_date": "20210721", "code_info": "Lots: a)N00418 Exp. 09/2022, b) N00417 Exp. 09/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72455", "recalling_firm": "Downing Labs, LLC", "address_1": "4001 McEwen Rd Suite 110", "address_2": "N/A", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US; Australia, Brazil, Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, Phillippines, Singapore, Thailand, Trinidad and Tobago, Taiwan", "recall_number": "D-0381-2016", "product_description": "Magnesium Sulfate Injection (4060mOsm/L), 50%, 50mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435", "product_quantity": "304 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151016", "center_classification_date": "20151118", "termination_date": "20160922", "report_date": "20151125", "code_info": "All lots"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1652-2019", "product_description": "EDETATE DISODIUM 15% INJECTABLE, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0922-30", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0901-2019", "product_description": "Aquaflora Phase II Candida Control Program, Net 16 fl. oz. (1 PT) 473 mL, Homeopathic Formula, Manufactured by: King Bio, Inc. 3 Westside Dr. Asheville, NC 28806 USA, UPC 357955160267, NDC 57955-1602-6", "product_quantity": "2248 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 010518G Exp. 07/18; 011617F Exp. 01/20; 021016G Exp. 02/19; 051716P Exp. 02/19; 072315A Exp. 07/18"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0894-2019", "product_description": "Dr. King's SafeCare Rx PSOR Miasm, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955030126, NDC 57955-0307-2", "product_quantity": "39 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 120217D Exp. 12/19"}, {"country": "United States", "city": "Lincoln", "address_1": "10401 Hwy 6", "reason_for_recall": "Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.", "address_2": "", "product_quantity": "398,208 cartons", "code_info": "Lot #: 10115134, Exp 5/31/2013; 10119862, Exp 7/31/2013; 10122276, 10124325, Exp 10/31/2013.", "center_classification_date": "20140117", "distribution_pattern": "Nationwide, Mexico, Russia, Korea, Panama, China, and Canada.", "state": "NE", "product_description": "Theraflu Flu & Chest Congestion (acetaminophen 1000 mg and guaifenesin 400 mg) powder packets, Natural Citrus flavor, 6-count packets per carton, Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ  07054-0622, NDC 0043-0483-06, UPC 3 0043-0483-06 1.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Novartis Consumer Health", "recall_number": "D-755-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65490", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20130618", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Newtown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209335"], "brand_name": ["OXYBUTYNIN CHLORIDE"], "generic_name": ["OXYBUTYNIN CHLORIDE"], "manufacturer_name": ["KVK-Tech, Inc."], "product_ndc": ["10702-201"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OXYBUTYNIN CHLORIDE"], "rxcui": ["863664"], "spl_id": ["289ec3ce-2fb1-608b-e063-6394a90a4a7a"], "spl_set_id": ["f99fdfe8-a980-4a72-bc99-aa2ce0bdfd86"], "package_ndc": ["10702-201-01", "10702-201-50", "10702-201-10"], "is_original_packager": [true], "unii": ["L9F3D9RENQ"]}, "product_type": "Drugs", "event_id": "81804", "recalling_firm": "KVK-Tech, Inc.", "address_1": "110 Terry Dr", "address_2": "", "postal_code": "18940-3427", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed by 10 major distributors throughout the United States.", "recall_number": "D-0340-2019", "product_description": "Oxybutynin Chloride Tablets, USP, 5 mg, 500-count bottle, Rx only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940, NDC 10702-201-50", "product_quantity": "156 bottles", "reason_for_recall": "Labeling: Wrong bar code", "recall_initiation_date": "20181211", "center_classification_date": "20181219", "termination_date": "20190501", "report_date": "20181226", "code_info": "Lot #: 15079A, Exp 10/20", "more_code_info": ""}, {"status": "Terminated", "city": "Cheshire", "state": "CT", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA125166"], "brand_name": ["SOLIRIS"], "generic_name": ["ECULIZUMAB"], "manufacturer_name": ["Alexion Pharmaceuticals Inc."], "product_ndc": ["25682-001"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ECULIZUMAB"], "rxcui": ["700384", "700387"], "spl_id": ["25021c88-95e1-42f0-b895-921526b90642"], "spl_set_id": ["ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722"], "package_ndc": ["25682-001-01"], "is_original_packager": [true], "nui": ["N0000175575", "N0000175974"], "pharm_class_epc": ["Complement Inhibitor [EPC]"], "pharm_class_moa": ["Complement Inhibitors [MoA]"], "unii": ["A3ULP0F556"], "upc": ["325682001016"]}, "product_type": "Drugs", "event_id": "66771", "recalling_firm": "Alexion Pharmaceuticals, Inc.", "address_1": "352 Knotter Dr", "address_2": "", "postal_code": "06410-1138", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide, Puerto Rico, Jamaica, and Grenada.", "recall_number": "D-1049-2014", "product_description": "Soliris (eculizumab) Concentrated Solution for Intravenous Infusion Only, 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by: Alexion Pharmaceuticals, Inc., Cheshire, CT  06410, NDC 25682-001-01, UPC 3 25682-001-01 6.", "product_quantity": "21,661 vials", "reason_for_recall": "Presence of Particulate Matter: Failed the appearance test for the presence of visible particles.", "recall_initiation_date": "20131104", "center_classification_date": "20140130", "termination_date": "20150302", "report_date": "20140205", "code_info": "Lot #: 10001-1, Exp 07/14; 10010A, Exp 10/15", "more_code_info": ""}, {"country": "United States", "city": "Staten Island", "address_1": "119 Linwood Ave", "reason_for_recall": "Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.", "address_2": "", "product_quantity": "unknown", "code_info": "All Lots", "center_classification_date": "20180228", "distribution_pattern": "NY and NJ through six retail stores named \"Asian Food Markets\"", "state": "NY", "product_description": "ZHANSHENG WEIGE CHAOYUE XILISHI tablets, 2000 mg, 6-count bottle, labeling is in foreign language", "report_date": "20180207", "classification": "Class I", "openfda": {}, "recalling_firm": "A&H Focal Inc.", "recall_number": "D-0562-2018", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "76644", "termination_date": "20190614", "more_code_info": "", "recall_initiation_date": "20170307", "postal_code": "10305-4445", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211892"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-440", "16729-441", "16729-442"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["40aa0834-3fd8-c230-e063-6294a90a800d"], "spl_set_id": ["6bad4e06-c0a1-4123-83c2-67d3b081e8a9"], "package_ndc": ["16729-440-10", "16729-440-15", "16729-440-01", "16729-441-10", "16729-441-15", "16729-441-01", "16729-442-10", "16729-442-15", "16729-442-01"], "is_original_packager": [true], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95501", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and PR", "recall_number": "D-0031-2025", "product_description": "Cinacalcet Tablets, 60 mg, Rx Only, a) 30 Tablets per bottle, NDC: 16729-441-10, b) 90 Tablets per bottle, NDC: 16729-441-15, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, INDIA.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.", "recall_initiation_date": "20241010", "center_classification_date": "20241031", "report_date": "20241106", "code_info": "a) Lot #:              Expiry Date: M2204481              02/2025 M2212389              08/2025 M2214271              09/2025 M2215970              10/2025 M2216458              10/2025  b) Lot #:             Expiry Date: M2212869           08/2025 M2216362           09/2025 M2215969           10/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Detroit", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68786", "recalling_firm": "Caraco Pharmaceutical Laboratories, Ltd.", "address_1": "1150 Elijah McCoy Dr", "address_2": "N/A", "postal_code": "48202-3344", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1510-2014", "product_description": "Cephalexin Capsules, USP, 250 mg, packaged in a) 100-count bottles (NDC 62756-293-88) and b) 500-count bottles (NDC 62756-293-13), Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., Acme Plaza, Andheri-Kurla Road, Andheri (East), Mumbai-400 059, India.", "product_quantity": "a) 70,152 bottles; b) 43,525 bottles", "reason_for_recall": "CGMP Deviations: These products are being recalled because they were manufactured with active pharmaceutical ingredients (APIs) that were not manufactured with good manufacturing practices.", "recall_initiation_date": "20140626", "center_classification_date": "20140801", "termination_date": "20150309", "report_date": "20140813", "code_info": "Lot #: a) AGL0098B, AGL0099B, AGL0100B, AGL0101B, Exp 09/14; AGM0073B, AGM0074B, Exp 04/15; AGM0125B, AGM0126B, Exp 07/15; AGM0158B, Exp 09/15; b) AGL0092A, AGL0093A, AGL0094A, AGL0095A,  AGL0096A, AGL0097A, AGL0102A, AGL0103A, AGL0104A, AGL0105A, Exp 09/14; AGM0067A, AGM0068A, AGM0069A, Exp 03/15; AGM0070A, AGM0071A, AGM0072A, AGM0085A, AGM0086A, Exp 04/15; AGM0127A, AGM0128A, AGM0129A, AGM0130A, AGM0131A, AGM0132A, Exp 07/15"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0041-2023", "product_description": "PAP/PHEN/PROSTAG/ATROPINE INJ 150MG/7.5MG/75MCG/1MG bottle solution, 5 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lots: 66369, BUD: 11/06/2022; 66540, BUD: 11/09/2022"}, {"country": "United States", "city": "Princeton", "address_1": "107 College Rd E", "reason_for_recall": "Failed impurities/degradation specification: An out of specification results has been determined for an individual related substance during stability testing at the 18th month interval for the Famotidine 10 mg Tablet, USP.", "address_2": "", "product_quantity": "84,240 bottles", "code_info": "Lot # 79405008A, 79405008B, 79405008C, Exp 05/2017", "center_classification_date": "20160630", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "CVS pharmacy Original Strength Acid Controller tablets, 10 mg, 30-count bottle, OTC,  Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895, UPC 150049523", "report_date": "20160706", "classification": "Class III", "openfda": {}, "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "recall_number": "D-1058-2016", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "74220", "termination_date": "20170426", "more_code_info": "", "recall_initiation_date": "20160422", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; VITAMIN B COMPLEX PROLONGED RELEASE Tablet may be potentially mislabeled as    guaiFENesin ER, Tablet, 600 mg, NDC 63824000815, Pedigree: AD73627_23, EXP: 5/30/2014;  TOLTERODINE TARTRATE ER, Capsule, 4 mg, NDC 00009519101, Pedigree: AD73686_1, EXP: 5/31/2014.", "address_2": "", "product_quantity": "120 Tablets", "code_info": "VITAMIN B COMPLEX PROLONGED RELEASE Tablet has the following codes    Pedigree: AD73627_26, EXP: 5/30/2014;  Pedigree: AD76686_1, EXP: 5/31/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "VITAMIN B COMPLEX PROLONGED RELEASE Tablet, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 40985022251", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-551-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-644-2015", "product_description": "D-Penicillamine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0416-2020", "product_description": "ActivEyes Altachlore Sodium Chloride Hypertonicity Opthalmic Ointment, 5%, Manufactured by: Altaire Pharmaceuticals Inc.  Aquebogue, NY 11931, NDC 59390-184-50", "product_quantity": "46345 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "SAP 1/20 3/16/2018   SFI 6/20 8/16/2018   SLA 12/20 1/4/2019   TBM 2/21"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-957-2013", "product_description": "ESTRIOL 5 MG/ML OIL INJ SOLN, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "02042013@21, 02262013@3, 07242013@38", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77780", "recalling_firm": "Cantrell Drug Company", "address_1": "7321 Cantrell Rd", "address_2": "N/A", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-1070-2017", "product_description": "Norepinephrine Bitartrate 8 mg Added to 0.9% Sodium Chloride 250 mL (32 mcg per mL) Single-Dose Bag, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222, NDC 52533-217-18", "product_quantity": "8928 bags", "reason_for_recall": "Lack of Sterility Assurance.", "recall_initiation_date": "20170714", "center_classification_date": "20170809", "termination_date": "20200916", "report_date": "20170816", "code_info": "Lot #: 10095, BUD: 7/27/2017; 10119, BUD: 7/31/2017; 10135, BUD: 8/2/2017; 10162, BUD: 8/6/2017; 10168, BUD: 8/7/2017; 10186, BUD: 8/9/2017; 10247, BUD: 8/15/2017; 10301, BUD: 8/21/2017; 10325, BUD: 8/24/2017; 10390, BUD: 9/5/2017; 10465, BUD: 9/18/2017; 10487, BUD: 9/20/2017; 10542, BUD: 9/27/2017"}, {"country": "United States", "city": "Norwalk", "address_1": "14831 Piuma Ave", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis detected the presence of sibutramine.", "address_2": "", "product_quantity": "591 boxes", "code_info": "Best By Date: 9/2021", "center_classification_date": "20210817", "distribution_pattern": "Distribution Nationwide in the USA via the internet and to the following countries Brazil, Canada, Germany, France, Hong Kong, Italy, Sweden, Switzerland, Thailand, and United Kingdom.", "state": "CA", "product_description": "Vy&Tea (Vietnamese Labeling with a green leaf and a bird underneath) 15/KLT 45.0G (15 tea sachets per box), Manufactured by Havyco No. 45, Group 1, National Highway 14, Son Hiep Hamlet, Tho Son Commune, Bu Dang District, Binh Phuoc Province, Vietnam, Website: trathaomocgiamcan.com.", "report_date": "20210811", "classification": "Class I", "openfda": {}, "recalling_firm": "Qikmoov LLC", "recall_number": "D-0749-2021", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "88280", "more_code_info": "", "recall_initiation_date": "20210714", "postal_code": "90650-5339", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0772-2018", "product_description": "Revlimid 15 mg oral cap NDC 59572-0415-21 28 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Highland", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89334", "recalling_firm": "ULTRAtab Laboratories, Inc.", "address_1": "50 Toc Dr", "address_2": "N/A", "postal_code": "12528-1506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Bulk product was distributed to 3 distributors who may have distributed finished product.", "recall_number": "D-0545-2022", "product_description": "Phenylephrine HCl 5 mg Tablet (Phenylephrine HCl 5mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY  NDC 62959-333-00", "product_quantity": "4,531,580 tablets", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20220126", "center_classification_date": "20220209", "termination_date": "20250107", "report_date": "20220216", "code_info": "Product Codes: M333  Bulk Lots: 18M065, 19J078"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206977"], "brand_name": ["TIROSINT"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["IBSA Pharma Inc."], "product_ndc": ["71858-0105", "71858-0110", "71858-0112", "71858-0113", "71858-0115", "71858-0117", "71858-0120", "71858-0125", "71858-0130", "71858-0135", "71858-0140", "71858-0145", "71858-0150", "71858-0155", "71858-0160"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["2056462", "2056466", "2056468", "2056470", "2056472", "2056474", "2056476", "2056478", "2056480", "2056482", "2056484", "2056486", "2056488", "2056490", "2056492", "2056494", "2056496", "2056498", "2056500", "2056502", "2056504", "2056506", "2056508", "2056510", "2566608", "2566610", "2566613", "2566615", "2566617", "2566619"], "spl_id": ["2c23d44e-1a15-f636-e063-6294a90a0ed4"], "spl_set_id": ["5d378add-f13d-40f2-99dc-0f2340ab44b7"], "package_ndc": ["71858-0105-6", "71858-0105-4", "71858-0105-5", "71858-0105-1", "71858-0105-2", "71858-0110-6", "71858-0110-4", "71858-0110-5", "71858-0110-1", "71858-0110-2", "71858-0112-6", "71858-0112-4", "71858-0112-5", "71858-0112-1", "71858-0112-2", "71858-0113-6", "71858-0113-4", "71858-0113-5", "71858-0113-1", "71858-0113-2", "71858-0115-6", "71858-0115-4", "71858-0115-5", "71858-0115-1", "71858-0115-2", "71858-0117-6", "71858-0117-4", "71858-0117-5", "71858-0117-1", "71858-0117-2", "71858-0120-6", "71858-0120-4", "71858-0120-5", "71858-0120-1", "71858-0120-2", "71858-0125-6", "71858-0125-4", "71858-0125-5", "71858-0125-1", "71858-0125-2", "71858-0130-6", "71858-0130-4", "71858-0130-5", "71858-0130-1", "71858-0130-2", "71858-0135-6", "71858-0135-4", "71858-0135-5", "71858-0135-1", "71858-0135-2", "71858-0140-6", "71858-0140-4", "71858-0140-5", "71858-0140-1", "71858-0140-2", "71858-0145-6", "71858-0145-4", "71858-0145-5", "71858-0145-1", "71858-0145-2", "71858-0150-6", "71858-0150-4", "71858-0150-5", "71858-0150-1", "71858-0150-2", "71858-0155-6", "71858-0155-4", "71858-0155-5", "71858-0155-1", "71858-0155-2", "71858-0160-6", "71858-0160-4", "71858-0160-5", "71858-0160-1", "71858-0160-2"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "91556", "recalling_firm": "IBSA PHARMA INC", "address_1": "8 Campus Dr Ste 201", "address_2": "N/A", "postal_code": "07054-4409", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0331-2023", "product_description": "TIROSINT - SOL (levothyroxine sodium) Oral Solution, 13 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0105-5", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20230130", "center_classification_date": "20230404", "termination_date": "20231031", "report_date": "20230301", "code_info": "Lot #: 220409, Exp. 10/2023; 220956, Exp. 03/2024."}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1013-2017", "product_description": "fentaNYL 10 mcg/mL PF in Sodium Chloride 250 mL (Total Dose=2500 mcg), Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0229-40", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lots: 20170509@20 BUD: 8/7/2017; 20170509@21 BUD: 8/7/2017; 20170509@46 BUD: 8/7/2017; 20170511@33 BUD: 8/9/2017"}, {"status": "Ongoing", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95944", "recalling_firm": "Akron Pharma, Inc.", "address_1": "373 Us Highway 46 Ste 117", "address_2": "", "postal_code": "07004-2456", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0193-2025", "product_description": "Acetaminophen Extra Strength 500 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8022-01.", "product_quantity": "768 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.", "recall_initiation_date": "20241212", "center_classification_date": "20250110", "report_date": "20250122", "code_info": "Lot: KDT0224002A, Exp 09/30/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Richardson", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89954", "recalling_firm": "North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding", "address_1": "1736 N Greenville Ave", "address_2": "", "postal_code": "75081-1808", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within United States", "recall_number": "D-0777-2022", "product_description": "Ipamorelin Acetate/Sermorelin Acetate (1 mg/1 mg)/mL (10 mL) Injection, 10 mL vials, Rx Only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081", "product_quantity": "189 vials", "reason_for_recall": "Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20220405", "center_classification_date": "20220421", "termination_date": "20231005", "report_date": "20220427", "code_info": "Lot #: 32961 BUD: 5/12/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Charlottesville", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93150", "recalling_firm": "Biomic Sciences, LLC dba ION Intelligence of Nature", "address_1": "4351 Seminole Trl", "address_2": "N/A", "postal_code": "22911-8225", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the United States and to Canada, New Zealand, Australia, Indonesia, Malaysia, Great Britain, and the Netherlands", "recall_number": "D-0068-2024", "product_description": "ION* Sinus Support Nasal Spray, 1 fl oz/30 ml bottles, Manufactured by: ION* Intelligence of Nature Charlottesville, VA", "product_quantity": "N/A", "reason_for_recall": "Microbial contamination of Non-Sterile Products", "recall_initiation_date": "20230929", "center_classification_date": "20231024", "termination_date": "20240710", "report_date": "20231101", "code_info": "All lots within expiry."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: MULTIVITAMIN/MULTIMINERAL, Tablet, 0 mg may have potentially been mislabeled as one of the following drugs:  sitaGLIPtin PHOSPHATE, Tablet, 50 mg, NDC 00006011231, Pedigree: AD62829_11, EXP: 5/23/2014;  LORATADINE, Tablet, 10 mg, NDC 45802065078, Pedigree: W002652, EXP: 6/5/2014;  LORATADINE, Tablet, 10 mg, NDC 45802065078, Pedigree: AD22865_7, EXP: 5/2/2014;  MULTIVITAMIN/M", "address_2": "", "product_quantity": "1603 Tablets", "code_info": "MULTIVITAMIN/MULTIMINERAL, Tablet, 0 mg has the following codes:   Pedigree: AD62992_8, EXP: /23/2014;  Pedigree: W002653, EXP: 6/5/2014;  Pedigree: AD22865_10, EXP: 5/2/2014;  Pedigree: AD22865_13, EXP: 5/2/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MULTIVITAMIN/MULTIMINERAL, Tablet, 0 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536406001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-938-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1404-2016", "product_description": "2.5 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Yellow Smiths Medical Cassette, Service Code 2K8892, Rx Only,  Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-882-48", "product_quantity": "85 Medical Cassettes", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Service Code 2K8892 , Lot Number 160560168M , Exp. Date 5/17/2016 ;  Service Code 2K8892 , Lot Number 160810001M , Exp. Date 6/10/2016 ;  Service Code 2K8219 , Lot Number 160530297M , Exp. Date 5/23/2016 ;", "more_code_info": ""}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82827", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1442-2019", "product_description": "Pramipexole Dihydrochloride Tablets 0.125 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-196-10", "product_quantity": "204  1000-count bottles", "reason_for_recall": "CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.", "recall_initiation_date": "20190506", "center_classification_date": "20190701", "termination_date": "20210916", "report_date": "20190626", "code_info": "Lot: M714919, EXP Dec-19, M815081, EXP Aug-20, M900475, EXP Dec-20"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0428-2021", "product_description": "Timolol Maleate Ophthalmic Solution, USP 0.5% 2.5 mL Sterile For Topical Application In The Eye Rx Only NDC 60505-1005-4 Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, FL 33326", "product_quantity": "31 droptainers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "RV7378"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-586-2015", "product_description": "Cimetidine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77191", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0914-2017", "product_description": "VANCOMYCIN HCl 1.5g in 300 mL 0.9% Sodium Chloride Injection USP, Service Code 2K2243, NDC# 61553-043-34, Total Volume 300.00 mL incorrectly labeled as 500.00 mL, Rx Only, PharMEDium Services, LLC, 12620 W. Airport Blvd #130, Sugar Land, TX 74478", "product_quantity": "816 bags", "reason_for_recall": "Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.", "recall_initiation_date": "20170217", "center_classification_date": "20170612", "termination_date": "20170613", "report_date": "20170621", "code_info": "Lot Numbers: 170200039S, 2/22/2017; 170230182S, 170230137S, 2/23/2017; 170260122S, 2/26/2017; 170300085S, 3/2/2017; 170320048S, 3/4/2017; 170340152S, 3/8/2017; 170380097S, 3/10/2017"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Testosterone Cypionate 200mg/ml", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1138-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0284-2020", "product_description": "S-TEST CYP 50MG/ML MDV IN ETHYL OLEATE OIL, Rx Only, 5ml glass vial, Red Mountain Compounding Rx", "product_quantity": "1x5ml glass vial", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S06162019DH@02, Exp 9/16/19;"}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0240-2024", "product_description": "Old Spice, SWEAT DEFENSE PURE SPORT PLUS, Dry Spray,  (Aluminum Chlorohydrate 23.5%), Anti-Perspirant, Topical spray can, Net WT 3.8 oz (107 g) cans,  Distr. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-387-10, UPC 0 37000 72974 7", "product_quantity": "unknown", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "Lot #: 12081458SB, Exp 6/30/2021; 92181458FA, Exp 7/31/21;"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: NIACIN, Tablet, 500 mg may have potentially been mislabeled as one of the following drugs:  NAPROXEN, Tablet, 500 mg, NDC 53746019001, Pedigree: AD54516_1, EXP: 5/20/2014;  DOCUSATE SODIUM, Capsule, 250 mg, NDC 00904789159, Pedigree: W002920, EXP: 6/10/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "NIACIN, Tablet, 500 mg has the following codes:   Pedigree: AD52993_10, EXP: 5/20/2014;  Pedigree: W002957, EXP: 6/10/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NIACIN, Tablet, 500 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904227260.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1028-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71013", "recalling_firm": "Reckitt Benckiser LLC", "address_1": "399 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1133", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1368-2015", "product_description": "Mucinex Fast Max Day Time Severe Congestion & Cough Night Time Cold & Flu, Maximum Strength, Two - 6 fl oz (180 mL) bottles Total - 12 fl oz (360 mL), For Ages 12+, Dist. by Reckitt Benckiser Parsippany, NJ 07054-0224, Made in India, NDC 63824-528-22-01, NDC 63824-528-22-00, UPC 63824-52822-9", "product_quantity": "561,390 Bottles", "reason_for_recall": "Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenesin. As a result certain safety warnings associated with those ingredients may also be missing.", "recall_initiation_date": "20150415", "center_classification_date": "20150825", "termination_date": "20180309", "report_date": "20150902", "code_info": "Lot #:                                Exp:  WO00707825 5/31/2016  WO00713226                 7/31/2016  WO00715310 6/30/2016  WO00715505 7/31/2016  WO00721174 9/30/2016  WO00721177 10/31/2016  WO00726860 10/31/2016  WO00726862 6/30/2016  WO00726952 8/31/2016  WO00728861 6/30/2016  WO00728878 7/31/2016  WO00728879 9/30/2016"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-509-2015", "product_description": "Amantadine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "23000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Randolph", "address_1": "540 Route Ten West", "reason_for_recall": "Non-Sterility: Pharmacy Creations is recalling Ascorbic Acid 500 mg/mL 50 mL vials due to mold contamination.", "address_2": "", "product_quantity": "70 vials", "code_info": "Lot: 06062014@8, Do Not Use Beyond 12/03/2014", "center_classification_date": "20140819", "distribution_pattern": "NY, NJ, and Puerto Rico", "state": "NJ", "product_description": "Ascorbic Acid 500 mg/mL Sterile Injection, 50 mL Multi-dose Vial, Rx only, Pharmacy Creations, Randolph, NJ 07869.", "report_date": "20140827", "classification": "Class I", "openfda": {}, "recalling_firm": "Pharmacy Creations", "recall_number": "D-1546-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "68669", "termination_date": "20160919", "more_code_info": "", "recall_initiation_date": "20140625", "postal_code": "07869", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-996-2013", "product_description": "SELENIUM  400 MCG/ML INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "03282013@4", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-635-2015", "product_description": "Dobutamine Hydrochloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "4997 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA085082"], "brand_name": ["DICYCLOMINE HYDROCHLORIDE"], "generic_name": ["DICYCLOMINE HYDROCHLORIDE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-0794", "0591-0795"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DICYCLOMINE HYDROCHLORIDE"], "rxcui": ["991061", "991086"], "spl_id": ["cdc9e5f4-36d9-40dc-894f-2d8682e4a61b"], "spl_set_id": ["a5937c7b-cdfc-46e6-a0fa-541b24f91d47"], "package_ndc": ["0591-0794-01", "0591-0794-10", "0591-0795-01", "0591-0795-10"], "is_original_packager": [true], "upc": ["0305910795016", "0305910794019"], "unii": ["CQ903KQA31"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0175-2024", "product_description": "Dicyclomine Hydrochloride Tablets, USP 20 mg, 100 Tablets, Rx only, Manufactured For: Teva Pharmaceuticals USA, Parsippany, NJ 07054.  NDC: 0591-0795-01", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 3197790", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "28 units", "code_info": "Rx #'s:  0388316    0388963      0389126    0389635    0391611      0406215    0395252    0392864    0395978    0390748    0390748          0390748    0391630    0391630    0390748    0400319    0388489    0388489    0389320    0390209    0403997    0382211    0381428", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "EDTA  DISODIUM SOLUTION 33.6MG/ML (0.1 MOLAR) OPHTHALMIC 15 ML;  EDTA CALCIUM DISODIUM (PRESERVATIVE FREE) 150MG/ML INJECTABLE 100 ML, 2400 ML, 500 ML; EDTA CALCIUM DISODIUM SOLUTION  2% OPHTHALMIC 5 ML; EDTA DISODIUM (P.F.) 150MG/ML INJECTABLE 1000 ML, 1200 ML, 1500 ML, 400 ML, 500 ML, 900 ML; EDTA DISODIUM (PRESERVATIVE FREE) 150MG/ML INJECTABLE 1000 ML, 2000 ML, 8000 ML;  EDTA DISODIUM (PRESERVATIVE FREE) 3%/ML INJECTABLE 12 ML; EDTA DISODIUM IN NATURAL TEARS  1.5% OPHTHALMIC 5 ML; EDTA DISODIUM IN NATURAL TEARS  3% OPHTHALMIC 15 ML,\t 30 ML (18 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1512-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "10 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "papaverine phentolamine prostaglandin; 35/1.2 mg/20 mcg/mL; 10 mL unit size, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0710-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "65172", "recalling_firm": "King Legacy, a wholly owned subsidiary of Pfizer", "address_1": "501 5th Street", "address_2": "N/A", "postal_code": "37620-2304", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-423-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and b) 1000-count bottles (NDC 60793-852-10), Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620", "product_quantity": "194,142 bottles", "reason_for_recall": "Subpotent Drug: The products were below specification for potency at the expiry stability point.", "recall_initiation_date": "20130430", "center_classification_date": "20130520", "termination_date": "20160630", "report_date": "20130529", "code_info": "Lot # a) 64197, Exp. 4/13; 64339, Exp. 4/13; 65061, Exp. 5/13; 65236, Exp. 6/13; 65917, Exp. 8/13; 66122, Exp. 8/13; and 66427, Exp. 9/13; b) 64340, Exp. 4/13; 64933, Exp. 4/13; 65062, Exp. 5/13; 65237, Exp. 6/13; 65238, Exp. 6/13; and 66121, Exp. 8/13"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-664-2015", "product_description": "Etodolac active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "2500 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; traZODone HCl Tablet, 150 mg may be potentially mislabeled as    NICOTINE POLACRILEX, Lozenge, 2 mg, NDC 00135051001, Pedigree: AD21858_1, EXP: 5/1/2014;  SENNOSIDES, Tablet, 8.6 mg, NDC 00182109301, Pedigree: W003256, EXP: 6/17/2014.", "address_2": "", "product_quantity": "300 Tablets", "code_info": "traZODone HCl, Tablet, 150 mg has the following codes    Pedigree: AD21858_7, EXP: 5/1/2014;  Pedigree: W003245, EXP: 6/17/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "traZODone HCl Tablet, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 50111044101", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-594-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "San Juan Del Rio", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86162", "recalling_firm": "Albek De Mexico S.A. De C.V.", "address_1": "Oriente Cuatro No. 11 Nuevo", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0081-2021", "product_description": "Assured Instant Hand Sanitizer Vitamin E and Aloe (Ethyl Alcohol 70% v/v), 8 fl oz/ 237 mL bottle, Distributed By: Greenbrier International, Inc. 500 Volvo Parkway, Chesapeake, VA 23320. Made in Mexico, UPC 639277928597", "product_quantity": "19,992 bottles", "reason_for_recall": "CGMP Deviations: Next Advanced Antibacterial Hand Sanitizer was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.", "recall_initiation_date": "20200730", "center_classification_date": "20201117", "report_date": "20201125", "code_info": "1931101AL"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0964-2019", "product_description": "Dr. King's Natural Medicine Regional Allergies Eastern Canada, 59 mL, (liquid/liquide) DIN-HM 80075212 UPC 357955181620", "product_quantity": "957 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 060917E Exp. 06/20; 021517K Exp. 02/20"}, {"status": "Terminated", "city": "Spokane", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83253", "recalling_firm": "First Pharma Associates LLC dba Riverpoint Pharmacy", "address_1": "1802 N Monroe St", "address_2": "", "postal_code": "99205-4528", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "ID, WA only", "recall_number": "D-1482-2019", "product_description": "PAP/PHEN/PGE1 18 mg/0.6mg/5.88mcg/mL Injection, 5 mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252", "product_quantity": "5 mL", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20190626", "center_classification_date": "20190711", "termination_date": "20230606", "report_date": "20190717", "code_info": "Lot #: 06152019@1, Exp. 08/2/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70118", "recalling_firm": "Walgreens Infusion Services", "address_1": "9030 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2504", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas, Florida, Virginia, Georgia, Louisiana, Mississippi", "recall_number": "D-0358-2015", "product_description": "Levofloxacin various strengths in normal saline", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20141226", "center_classification_date": "20150116", "termination_date": "20150724", "report_date": "20150128", "code_info": "All products within expiry."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1007-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10% with CALCIUM, total volume = 250mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043,NDC: 72196-0407-1", "product_quantity": "156 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251206, Exp. 7/10/2023."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0188-2019", "product_description": "Sterile Water 50 mL Aqueous Solution, Pharm D Solutions, Houston, Texas --- NDC 69699-1421-50", "product_quantity": "10 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 08092018:38 Discard by: 2/5/2018"}, {"country": "United States", "city": "Bartlesville", "address_1": "139 Se Katherine Ave", "reason_for_recall": "CGMP Deviations: Cylinders filled using out of date gauges.", "address_2": "", "product_quantity": "a) 289 M6-Tank Cylinders, b) 49 D-Tank Cylinders, c) 743 E-Tank Cylinders.", "code_info": "a) Lot #'s: 202166, 202167, 202168, 120164, 120165, 120166, 112161, 112162, 107161, 1230151, 1212151, 1212152, 1212153, 1208154, 1208155, 1208156, 1204152, 1204153, 1203151, 1116156, 1112151, 1112152.  b) Lot #'s: 120164, 1212153, 1208154, 1204151, 1116156, 1112151.  c)  Lot #'s: 202161, 202162, 202163, 202164, 202165, 120161, 120162, 120163, 120164, 119161, 119162, 119163, 112163, 112164, 107162, 107163, 1230152, 1208151, 1208152, 1208153, 1204152, 1203152, 1203153, 1202151,  1202152, 1202153, 1125151, 1125152, 1116151, 1116152,  1116153, 1116154, 1116155, 1116156, 1112151, 1109151, 1109152, 1109153, 1109154, 1109155, 1109156, 1103151, 1103152, 1103153, 1103154, 1102151, 1102152, 1102153, 1102154.", "center_classification_date": "20160315", "distribution_pattern": "U.S. Including: Oklahoma", "state": "OK", "product_description": "Oxygen, Compressed USP (Gaseous, Medical Oxygen, Aluminum Cylinders), Packaged in a) M6-Tanks, b) D-Tanks, and c) E-Tanks, Rx Only.  Medical Park Homecare, 139 SE Katherine Ave., Bartlesville, OK 74006.", "report_date": "20160323", "classification": "Class III", "openfda": {}, "recalling_firm": "Medical Park Homecare, Inc", "recall_number": "D-0776-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "73342", "termination_date": "20161123", "more_code_info": "", "recall_initiation_date": "20160205", "postal_code": "74006-2316", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Gentamicin Sulfate all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0820-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Memphis", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89986", "recalling_firm": "McKesson Corporation dba McKesson Drug Company", "address_1": "4853 Crumpler Rd", "address_2": "N/A", "postal_code": "38141-8301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States including Guam and the Northern Mariana Islands.", "recall_number": "D-0850-2022", "product_description": "Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented) (Potency expressed as betamethasone), 15 gram tube, Rx Only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-996-65", "product_quantity": "55,440 tubes", "reason_for_recall": "CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.", "recall_initiation_date": "20220421", "center_classification_date": "20220505", "report_date": "20220511", "code_info": "Lot: 15644, Exp.: 05/31/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206073"], "brand_name": ["GLYXAMBI"], "generic_name": ["EMPAGLIFLOZIN AND LINAGLIPTIN"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0164", "0597-0182"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EMPAGLIFLOZIN", "LINAGLIPTIN"], "rxcui": ["1602109", "1602115", "1602118", "1602120"], "spl_id": ["b0c37b65-8580-4810-a4e2-08998e82b2b2"], "spl_set_id": ["ddbab689-f76c-488c-9613-4168d41dd730"], "package_ndc": ["0597-0182-70", "0597-0182-07", "0597-0182-03", "0597-0182-30", "0597-0182-39", "0597-0182-90", "0597-0164-30", "0597-0164-39", "0597-0164-90", "0597-0164-70", "0597-0164-07"], "is_original_packager": [true], "nui": ["N0000187059", "N0000187058", "N0000175912", "N0000175913"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]"], "unii": ["HDC1R2M35U", "3X29ZEJ4R2"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0455-2021", "product_description": "Glyxambi (empagliflozin and linagliptin) Tablets 25 mg/5 mg 30 tablets Rx only NDC 0597-0164-30 Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA", "product_quantity": "592 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3513"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0531-2018", "product_description": "Ursodiol USP for prescription compounding, packaged in  a) 100g (NDC 58597-8038-6); b) 500g (NDC 58597-8038-7), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "25000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 071316-1, Exp. 05/27/2019; b) 071316-1, Exp. 05/27/2019"}, {"status": "Terminated", "city": "Springfield", "state": "OR", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "82247", "recalling_firm": "Todd Holiday dba Sunstone Organics", "address_1": "4061 Main St Ste C", "address_2": "N/A", "postal_code": "97478-8136", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "California, Nebraska, Oregon, Washington", "recall_number": "D-0989-2019", "product_description": "Maeng Da Kratom, packaged in a) 20 count capsules (UPC 00859667007149), b) 60 count capsules (UPC 00859667007156), c) 150 count capsules (UPC 00859667007163) , Sunstone Organics Springfield, Oregon 97473, 541-972-3327.", "product_quantity": "N/A", "reason_for_recall": "MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS: Analysis of samples were positive for Salmonella.", "recall_initiation_date": "20190213", "center_classification_date": "20190311", "termination_date": "20230214", "report_date": "20190313", "code_info": "Lot #124A"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0988-2020", "product_description": "Triamcinolone Acetonide (PF) Injectable Suspension, TRIAMCINOLONE ACETONIDE (PF) [10ML] 50MG/ML INJ SUSP, For IM, IA, IT Use, 2 mL Single Use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC # 71283-0633-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 06132019+52446, Exp 7/17/2020; 11142019+53240, Exp 12/18/2020"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0320-2017", "product_description": "TriMix, Alprostadil/Phentolamine/Papaverine 100mcg/3mg/30mg/mL, (1 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "2 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 08022016F (12/08/2016)."}, {"status": "Terminated", "city": "North Chicago", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020478"], "brand_name": ["ULTANE"], "generic_name": ["SEVOFLURANE"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-4456"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["SEVOFLURANE"], "rxcui": ["200243", "541963"], "spl_id": ["4b7ba14d-8de1-4f87-910e-87fdd984b24d"], "spl_set_id": ["c9aa6489-5a36-44ed-9512-b996833d82f7"], "package_ndc": ["0074-4456-51"], "is_original_packager": [true], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["38LVP0K73A"]}, "product_type": "Drugs", "event_id": "78969", "recalling_firm": "AbbVie Inc.", "address_1": "1 N Waukegan Rd", "address_2": "", "postal_code": "60064-1802", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, OH", "recall_number": "D-0412-2018", "product_description": "Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by:  AbbVie Inc., North Chicago, IL 60064, USA. NDC 0074-4456-51", "product_quantity": "7,770 bottles", "reason_for_recall": "Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage.", "recall_initiation_date": "20180122", "center_classification_date": "20180209", "termination_date": "20180913", "report_date": "20180207", "code_info": "Lot #: 1088856, Exp 6/20", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021134"], "brand_name": ["NITROSTAT"], "generic_name": ["NITROGLYCERIN"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "product_ndc": ["0071-0417", "0071-0418", "0071-0419"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBLINGUAL"], "substance_name": ["NITROGLYCERIN"], "rxcui": ["198038", "198039", "198040", "207331", "207346", "207361"], "spl_id": ["a4adb400-de1d-4dd6-97d0-05d145bdf77d"], "spl_set_id": ["79ba021e-183c-4b4d-822e-4ff5ef54ca61"], "package_ndc": ["0071-0417-24", "0071-0418-24", "0071-0418-13", "0071-0419-24"], "is_original_packager": [true], "nui": ["N0000175415", "M0014874", "N0000009909"], "pharm_class_epc": ["Nitrate Vasodilator [EPC]"], "pharm_class_cs": ["Nitrates [CS]"], "pharm_class_pe": ["Vasodilation [PE]"], "unii": ["G59M7S0WS3"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1049-2022", "product_description": "Nitrostat (Nitroglycerin Sublingual Tablets, USP) 0.4 mg/tablet, 25-count bottle, Rx only, Distributed by: Pfizer Parke-Davis, Division of Pfizer Inc., NDC 0071-0418-13", "product_quantity": "1 carton/4 bottles per carton/25 tablets per bottle", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Peoria", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72241", "recalling_firm": "Kalman Health & Wellness, Inc. dba Essential Wellness Pharma", "address_1": "4625 N University St", "address_2": "N/A", "postal_code": "61614-5828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-332-2016", "product_description": "TRIMIX #1 Injection, 4.2 mL vials, Rx only, Essential Wellness PHARMACY, 4625 N. University, Peoria, IL 61614.", "product_quantity": "6 vials", "reason_for_recall": "Lack of Assurance of Sterility:  A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.", "recall_initiation_date": "20150903", "center_classification_date": "20151117", "termination_date": "20171229", "report_date": "20151125", "code_info": "Lot #: 071015, Exp 09/10/2015; 071715, Exp 09/17/2015; and 073015, Exp 09/30/2015"}, {"status": "Terminated", "city": "Davie", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74874", "recalling_firm": "Pharmatech LLC", "address_1": "4131 Sw 47th Ave", "address_2": "Suite 1403", "postal_code": "33314-4026", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1522-2016", "product_description": "Ninjacof-A (acetaminophen, chlophedianol HCl, pyrilamine maleate) Liquid, 160 mg/12.5 mg/12.5 mg in each 5 mL, 16 fl oz (473 mL) bottle, Manufactured for: Centurion Labs, LLC, Birmingham, AL  35243, NDC 23359-033-16.", "product_quantity": "1,332 bottles", "reason_for_recall": "CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.", "recall_initiation_date": "20160808", "center_classification_date": "20160927", "termination_date": "20240923", "report_date": "20161005", "code_info": "Lot #: 25321601, Exp 04/18"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0830-2019", "product_description": "Dr. King's SafeCare Rx Allergies: Dairy, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955219828, NDC 57955-2198-2", "product_quantity": "224 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 073115B Exp. 07/18; 062116B Exp. 06/19; 121216C Exp. 12/19"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1428-2016", "product_description": "5 mcg/mL HYDROmorphone HCl and 0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Baxter Intravia Bag, Service Code 2K8483, Rx Only,  Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-483-61", "product_quantity": "115 bags", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Lot Number 160380152M , Exp. Date 5/8/2016 ;  Lot Number 160400233M , Exp. Date 5/10/2016 ;  Lot Number 160540186M , Exp. Date 5/24/2016 ;  Lot Number 160660046M , Exp. Date 6/4/2016 ;  Lot Number 160730154M , Exp. Date 6/12/2016 ;  Lot Number 160750176M , Exp. Date 6/14/2016 ;  Lot Number 160760046M , Exp. Date 6/14/2016 ;  Lot Number 160800066M , Exp. Date 6/18/2016 ;  Lot Number 160820111M , Exp. Date 6/20/2016 ;  Lot Number 160960039M , Exp. Date 7/4/2016 ;", "more_code_info": ""}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "20 vials", "code_info": "Lot # t01-20-2017@80, Exp 4/23/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "FOLIC ACID 1ML SDV 10MG/ML INJ, Injection, 10mg/mL, Rx only, 1 mL glass/Single Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0717-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["OBAGI NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION TRIAL"], "generic_name": ["HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE"], "manufacturer_name": ["Obagi Cosmeceuticals LLC"], "product_ndc": ["62032-914"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "spl_id": ["bc389b46-a94e-4cc3-baec-73044c6a387f"], "spl_set_id": ["219c68dc-1e74-4136-9065-85466008d445"], "package_ndc": ["62032-914-01", "62032-101-36", "62032-140-05", "3620321013"], "is_original_packager": [true], "upc": ["362032101361"]}, "product_type": "Drugs", "event_id": "69569", "recalling_firm": "Obagi Medical Products", "address_1": "50 Technology Dr", "address_2": "N/A", "postal_code": "92618-2301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Mexico and Slovenia", "recall_number": "D-0234-2015", "product_description": "Obagi Nu-Derm Clear, AM PM 3, Skin Bleaching and Corrector Cream, Hydroquinone USP, 4%, Rx Only, Net Wt. 2 OZ. (57 g) bottle, Dist by OMP Inc, Long Beach CA 90802, Made in USA, NDC 62032-101-36", "product_quantity": "975 bottles", "reason_for_recall": "Labeling: Label Mix-Up; Containers of the Obagi Nu-Derm Clear pre-labeled bottles were inadvertently introduced into the Obagi Exfoderm Forte packaging line. Therefore customers which ordered Clear RX actually had contents of Exfoderm forte.", "recall_initiation_date": "20141017", "center_classification_date": "20141031", "termination_date": "20150429", "report_date": "20141112", "code_info": "Lot #: 13I1218, Product/Part #: 362032101361, Exp 09/30/2016"}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81946", "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)", "address_1": "1718 Northrock Ct", "address_2": "N/A", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1013-2019", "product_description": "Alprazolam Tablets, USP, 0.25 mg, 10x10 per carton, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.  NDC:  51079-788-20", "product_quantity": "10,281 UD cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications:  Elevated levels of a known impurity detected during 6-month RT stability interval.", "recall_initiation_date": "20190118", "center_classification_date": "20190320", "termination_date": "20200429", "report_date": "20190327", "code_info": "Lots: 3095198, 3096266, 3098776, EXP 05-2019"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202099"], "brand_name": ["ZENATANE"], "generic_name": ["ISOTRETINOIN"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-113", "55111-135", "55111-136", "55111-137"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ISOTRETINOIN"], "rxcui": ["197843", "197844", "197845", "403930", "1373333", "1373335", "1373337", "1605088"], "spl_id": ["d7d883f9-7d20-2c50-8023-e661b46dcd5b"], "spl_set_id": ["27b3cf26-f22e-5b70-1c24-009933b7c6ee"], "package_ndc": ["55111-135-79", "55111-135-81", "55111-136-79", "55111-136-81", "55111-137-79", "55111-137-81", "55111-113-79", "55111-113-81", "55111-113-78"], "is_original_packager": [true], "nui": ["N0000175607", "M0018962"], "pharm_class_epc": ["Retinoid [EPC]"], "pharm_class_cs": ["Retinoids [CS]"], "unii": ["EH28UP18IF"]}, "product_type": "Drugs", "event_id": "77353", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0885-2017", "product_description": "Zenatane (isotretinoin) Capsules, USP, 30 mg, 30-count (3 x 10 Prescription Packs) per carton, Rx Only, Manufactured By: Cipla Limited, Kurkumbh Village, Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 55111-113-81", "product_quantity": "223,650 cartons", "reason_for_recall": "Failed Dissolution Specifications: out of specification results observed for low dissolution.", "recall_initiation_date": "20170522", "center_classification_date": "20170602", "termination_date": "20181119", "report_date": "20170614", "code_info": "Lot #: KB50414, KB50456, Exp 05/17; KB50457, KB50458, KB50459, KB50460, Exp 06/17; KB50580, KB50581, KB50582, KB50583, KB50599, KB50600, Exp 07/17; KB50646, KB50647, KB50721, KB50722, KB50723, KB50724, Exp 09/17; KB50833, KB50834, KB50835, KB50836, KB50837, Exp 10/17; KB50902, KB50903, KB50904, Exp 11/17; KB60037, KB60038, KB60039, KB60040, KB60041, Exp 12/17;  KB60109, KB60110, KB60111, KB60112, KB60113, Exp 01/18; 01KB60249, 01KB60266, 01KB60268, 01KB60269, 01KB60284, Exp 03/18; 01KB60369, 01KB60372, 79KB60368, 79KB60371, Exp 05/18; 79KB60507, 79KB60508, 79KB60509, 79KB60510, 79KB60511, 79KB60512, 79KB60513, 79KB60514, 79KB60515, 79KB60516, Exp 07/18; 79KB60570, 79KB60571, 79KB60585, 79KB60586, Exp 08/18;"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202824"], "brand_name": ["DOXAZOSIN"], "generic_name": ["DOXAZOSIN"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-211", "16729-414", "16729-213", "16729-415"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXAZOSIN MESYLATE"], "rxcui": ["197625", "197626", "197627", "197628"], "spl_id": ["1fbdaa94-b68a-b934-e063-6294a90a8b77"], "spl_set_id": ["2830533c-ccdf-4401-b19c-763eeb1bc0a7"], "package_ndc": ["16729-414-01", "16729-414-17", "16729-211-01", "16729-211-17", "16729-213-01", "16729-213-17", "16729-415-01", "16729-415-17"], "is_original_packager": [true], "unii": ["86P6PQK0MU"], "upc": ["316729414012", "316729414173"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0387-2023", "product_description": "Doxazosin Tablets USP, 2 mg, Rx Only, Packaged as: a) 100-count bottle NDC 16729-414-01 UPC 3 16729 41401 2; b) 1,000-count NDC 16729-414-17 UPC 3 16729 41417 3; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703.  Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA", "product_quantity": "69,122 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) R2200401, Exp. Date 5/31/2024; R2200675, Exp. Date 5/31/2024; R2200676 Exp. Date 11/30/2024; R2201070, Exp. Date 7/31/2025;  b) R2200680, Exp. Date 9/30/2024;", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-929-2015", "product_description": "Ticarcillin Sodium/Potassium Clavulanate (30:1) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "6000 grams", "reason_for_recall": "Stability Data Does Not Support Expiry: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged without data to support the printed expiry date.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Estradiol Cypionate 2mg/cc  testosterone cypionoate 50mg", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1109-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Zebulon", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020080"], "brand_name": ["IMITREX"], "generic_name": ["SUMATRIPTAN"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["0173-0478", "0173-0739", "0173-0479"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["SUMATRIPTAN SUCCINATE"], "rxcui": ["758523", "860088", "1657160", "1657173"], "spl_id": ["311eb103-84ed-46fa-b42f-c5ff35f7d16b"], "spl_set_id": ["fee7d073-0b99-48f2-7985-0d8cf970894b"], "package_ndc": ["0173-0739-00", "0173-0739-02", "0173-0479-00", "0173-0478-00"], "is_original_packager": [true], "unii": ["J8BDZ68989"]}, "product_type": "Drugs", "event_id": "66988", "recalling_firm": "GlaxoSmithKline, LLC.", "address_1": "1011 North Arendell Ave", "address_2": "N/A", "postal_code": "27597-1217", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-387-2014", "product_description": "Imitrex STATdose System, Imitrex (sumatriptan succinate) Injection, 2 prefilled 0.5 mL syringe cartridges each containing 6 mg of sumatriptan for subcutaneous injection only, 1 imitrex STATdose Pen, 1 carrying case, Rx only, 6 mg, GlaxoSmithKline, Research Triangle Park, NC 27709, Made in Singapore, NDC 0173-0479-00", "product_quantity": "10,469 Systems", "reason_for_recall": "Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.", "recall_initiation_date": "20131106", "center_classification_date": "20131224", "termination_date": "20140820", "report_date": "20140101", "code_info": "Lot#: C636293, Exp: 06/15", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1010-2022", "product_description": "Epidural Tray, Nerve Block Single shot, Rx only, # 182207, MFG: Avanos Medical Sales LLC", "product_quantity": "1 case", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0701-2019", "product_description": "Dr. King's SafeCare Rx CS-Uterus Cancer Support, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955022121, NDC 57955-0247-2", "product_quantity": "19 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 092216D Exp. 09/19; 010118H Exp. 01/20"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0439-2021", "product_description": "AMOXICILLIN 500MG 100; NDC/UPC 65862001401; RX; TABLETS", "product_quantity": "373 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "SE5019062-A"}, {"status": "Terminated", "city": "Tlalnepantla De Baz", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86105", "recalling_firm": "Real Clean Distribuciones SA de CV", "address_1": "Recursos Petroleros", "address_2": "Fracc Industrial La Loma 3; Tlalnepantla De Baz", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1581-2020", "product_description": "BORN BASIC., ANTI-BAC HAND SANITIZER, 70% Alcohol, (Ethyl Alcohol 70%), packaged as a) 9.5 FL OZ (280 mL) bottle, UPC 8 40038 21462 4: b) 16.9 FL OZ (500 mL) bottle, UPC 8 40038 21456 3; and c) 34 FL OZ (1L) bottle, UPC 8 40038 21447 1; Made in Mexico; Distributed by Scent Theory Products, LLC, New York, NY 10018.", "product_quantity": "975,720 bottles", "reason_for_recall": "CGMP Deviations: Born Basic Anti Bac was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.", "recall_initiation_date": "20200723", "center_classification_date": "20200911", "termination_date": "20220527", "report_date": "20200923", "code_info": "Lots: a) 0133720, 0233720 b) 0833420, 0933420, 1333420, 1433420, 1533420, 1633420, 1733420, 1833420, 1933420, 2033420, 2133420,    2633420, 2733420, 2833420, 2933420 c) 0133420, 0233420, 0333420, 0433420, 0533420, 0633420"}, {"status": "Terminated", "city": "Pittsburgh", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93880", "recalling_firm": "Alpha Aromatics", "address_1": "294 Alpha Dr", "address_2": "N/A", "postal_code": "15238-2906", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two accounts in NC and MI", "recall_number": "D-0338-2024", "product_description": "Pure Care Foaming Mint Hand Sanitizer 62%, Distributed by: Air Scent International, 290 Alpha Drive, RIDC Industrial Park, Pittsburg, PA 15238 USA, www.airscent.com, NDC 75009-562.", "product_quantity": "676 gallons", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20240125", "center_classification_date": "20240216", "termination_date": "20240814", "report_date": "20240228", "code_info": "Lot # 2022-012884 Lot # 2023-002020 Lot # 2023-003532 Lot # 2023-003761"}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "address_2": "", "product_quantity": "", "code_info": "Lots: 8AE1884,   8BE1466,   8DE1318,   8CE1617,   8DE1319,   8EE1326,   8DE1611,   8DE1767,   8FE1350,   8FE1352,   8GE1736,   8GE1840,   8GE1859,   8HE1592,   8HE1593,   8HE1594,   8JE2234,   9CE3263,   8JE2233,   8LE2360,   8KE2704,   8ME2641,   8ME2642,   9AE2675,   9AE2676,   9CE3265,   9CE3881,   9DE2585,   9EE2501,   9EE2502,   9FE2825,   9FE2827,   9GE2657,   9GE3124,   9GE3122,   9HE3555", "center_classification_date": "20200313", "distribution_pattern": "Nationwide USA", "state": "MI", "product_description": "Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg, 65 tablets per bottle. [Brand, NDC] NDC Basic Care: 0113-7950-09; NDC CVS Health: 59779-950-09; NDC Equate: 49035-800-09; NDC Good Neighbor Pharmacy: 46122-533-09; NDC Kroger: 30142-891-09; NDC Topcare: 36800-950-09; NDC Up & Up: 11673-950-09; NDC Walgreens: 0363-0950-09", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Perrigo Company PLC", "recall_number": "D-1023-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84127", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191023", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Brooklyn", "address_1": "908 Dean St", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.", "address_2": "", "product_quantity": "84 bottles", "code_info": "All lots", "center_classification_date": "20160711", "distribution_pattern": "Nationwide and Puerto Rico", "state": "NY", "product_description": "PATCH-REMOUING PILL (For Facial Pigmentation), packaged in a bottle within a box, Kwang Chow Pharm. Ind. Corp., remaining labeling contains Chinese characters.", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Murray International Trading Co., Inc.", "recall_number": "D-1345-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "74017", "termination_date": "20180614", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "11238-3204", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]